We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants
NUVB.WS

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

Back to rankings

20 hedge funds and large institutions have $1.59M invested in Nuvation Bio Inc Warrants in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more funds holding

Funds holding: 19 → 20 (+1)

0.04% less ownership

Funds ownership: 1.8% → 1.76% (-0.04%)

29% less capital invested

Capital invested by funds: $2.26M → $1.59M (-$667K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IP
Intellectus Partners
California
+$400
2
UBS Group
UBS Group
Switzerland
+$11

Top Sellers

Rank Fund Capital Flow
1
CCA
Castle Creek Arbitrage
Colorado
-$10.7K
2
APM
Avidity Partners Management
Texas
-$136
3
Victory Capital Management
Victory Capital Management
Texas
-$85
4
Citadel Advisors
Citadel Advisors
Florida
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$1.29M – – –
6CM
2
683 Capital Management
New York
$83.5K – – –
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$26.7K – – –
BC
4
Boxer Capital
California
$26.7K – – –
Franklin Resources
5
Franklin Resources
California
$26.7K – – –
DM
6
Deerfield Management
New York
$16.7K – – –
HCM
7
Highbridge Capital Management
New York
$16.4K – – –
BlackRock
8
BlackRock
New York
$15.4K – – –
RSCM
9
Rock Springs Capital Management
Maryland
$13.4K – – –
SB
10
Samsara BioCapital
California
$13.3K – – –
CCA
11
Castle Creek Arbitrage
Colorado
$12.2K -$10.7K -80,000 -37%
GC
12
Greenlight Capital
New York
$10K – – –
ACP
13
Acuta Capital Partners
California
$9.08K – – –
APM
14
Avidity Partners Management
Texas
$8.95K -$136 -1,017 -1%
Citadel Advisors
15
Citadel Advisors
Florida
$7.33K -$6 -45 -0.1%
LGM
16
Logos Global Management
California
$6.67K – – –
Victory Capital Management
17
Victory Capital Management
Texas
$6.11K -$85 -640 -1%
CC
18
Clearline Capital
New York
$3.33K – – –
IP
19
Intellectus Partners
California
$1.39K +$400 +3,000 +28%
Barclays
20
Barclays
United Kingdom
$164 – – –
UBS Group
21
UBS Group
Switzerland
$8 +$11 +84 New

NUVB.WS Hedge Fund Activity: Q3 2023 in Review

20 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q3 2023, worth a combined $1.59M — down 29% from $2.26M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new NUVB.WS positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Intellectus Partners, adding an estimated $400. The largest seller was Castle Creek Arbitrage, cutting an estimated $10.7K.

  • 20 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q3 2023, up from 19 in Q2 2023.
  • Funds reported $1.59M of Nuvation Bio Inc Warrants stock for Q3 2023, down 29% quarter-over-quarter.
  • 1 fund opened new Nuvation Bio Inc Warrants positions in Q3 2023 and 0 closed out, a net change of +1 holder.
  • The largest Nuvation Bio Inc Warrants buyer in Q3 2023 was Intellectus Partners, an estimated $400 added.
  • The largest Nuvation Bio Inc Warrants seller in Q3 2023 was Castle Creek Arbitrage, an estimated $10.7K sold.

Based on aggregated 13F filings for Q3 2023.